Quiescence has been thought to be required for the retention of the full bi
ological potential of pluripotent hematopoietic stem cells (PHSCs). This hy
pothesis has been challenged recently by the observation that all murine PH
SCs cycle continuously and constantly contribute to steady-state blood cell
production. It was asked whether these observations could be extrapolated
to describe hematopoiesis in higher mammals. In this series of experiments,
the replicative history of PHSCs was examined in baboons by continuously a
dministering bromodeoxyuridine (BrdU) for more than 85 weeks. The results i
ndicate that under steady-state conditions, PHSCs remain largely quiescent
but do cycle, albeit at a far lower rate than previously reported for roden
t PHSCs. BrdU-labeled cycling PHSCs and progenitor cells were shown to have
an extensive proliferative capacity and to contribute to blood cell produc
tion for prolonged periods of time. The proportion of PHSCS entering cell c
ycle could, however, be rapidly increased by the in vivo administration of
granulocyte-colony stimulating factor. These data indicate that during stea
dy-state hematopoiesis, baboon PHSCs require prolonged periods of time to c
ycle and that the proportion of PHSCs in cycle is not fixed but can be alte
red by external stimuli. The relative quiescence of PHSCs observed in this
nonhuman primate model, in contrast to murine PHSCs, might explain the curr
ent barriers to genetic modification and ex vivo expansion of human PHSCs.
(Blood. 2001;97:3061-3068) (C) 2001 by The American Society of Hematology.